Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
Crunch Time: The Impact of Serialisation Requirements on Packaging Operations
Editorial Archive

Crunch Time: The Impact of Serialisation Requirements on Packaging Operations

The November deadline for including unique product identifiers on prescription drugs is putting a strain on multiple parts of the industry, much of which is ill-p...
Continue Reading →
From Concept to Solution: Designing to Enhance the Multiple Roles of Pharma Packaging
Editorial Archive

From Concept to Solution: Designing to Enhance the Multiple Roles of Pharma Packaging

When you walk into a store or pharmacy and see multiple similar products in the same competitive space, it is easy to understand the impact that packaging design ...
Continue Reading →
Mitigating Risk Roche’s Approach to PAT Implementation in a Sodium Borohydride Product
Editorial Archive

Mitigating Risk Roche’s Approach to PAT Implementation in a Sodium Borohydride Product

Many compounds are synthesised from raw materials in multi-batch and multi-ton quantities over extended time periods. The repetitious nature of the multi-batch bu...
Continue Reading →
Innovations for Prefillable Syringes
Editorial Archive

Innovations for Prefillable Syringes

The field of prefillable syringes is constantly turning up new trends and developments, driven by new active ingredients and a desire for patient safety at afford...
Continue Reading →
Future Supply Chain Trends: The Rise of the Full-service CDMO
Editorial Archive

Future Supply Chain Trends: The Rise of the Full-service CDMO

Outsourcing is on the rise, not only among big pharmaceutical firms but also with smaller emerging and even virtual companies, meaning customer requirements are ...
Continue Reading →
Environmental Monitoring and Reporting Facilitated by LIMS
Editorial Archive

Environmental Monitoring and Reporting Facilitated by LIMS

Environmental monitoring (EM) is an essential part of any pharmaceutical, medical device or biotechnology manufacturing process. It ensures that microbiological a...
Continue Reading →
The Advantages of LC/MS in Identifying Residual Impurities in Biopharmaceuticals
Editorial Archive

The Advantages of LC/MS in Identifying Residual Impurities in Biopharmaceuticals

Fergus Hall, PhD, Section Manager, Pharmaceutical Chemistry at Eurofins BioPharma Product Testing, looks at the complexity of detecting and quantifying residual i...
Continue Reading →
Working with Difficult Preparations – Risks, Regulations, and Considerations
Editorial Archive

Working with Difficult Preparations – Risks, Regulations, and Considerations

Safety testing is a crucial part of drug development and is dictated by pharmacopoeial guidelines, which must be followed when performing each step of the process...
Continue Reading →
Propelling Holistic Risk Management Using a Next-generation RBM Approach
Editorial Archive

Propelling Holistic Risk Management Using a Next-generation RBM Approach

As the nature of clinical trials grows ever more complex, the requirement for an improved risk-based monitoring (RBM) approach increases. Such an approach improve...
Continue Reading →
Will Graph Database Technology Uncover Pharma’s Hidden Insights?
Editorial Archive

Will Graph Database Technology Uncover Pharma’s Hidden Insights?

By definition, medical research is about dealing with large quantities of data. That’s even truer in the leading edges of the life sciences, where tackling the th...
Continue Reading →
Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025